Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

23Andme Holding Co. (NQ: ME )

2.690 -0.060 (-2.18%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 23Andme Holding Co.

< Previous 1 2 3 4 Next >
7 Former SPACs I Still Own (And What I Think Now)
Remember the SPAC boom? Here are seven products of that time that are still in my portfolio. 
Via The Motley Fool
23andMe to Report FY2023 Third Quarter Financial Results
From 23andMe Holding Co.
Via Globe NewsWire
3 Penny Stocks That Could Make You Filthy Rich
These low-priced equities could deliver enormous returns for risk-tolerant shareholders. 
Via The Motley Fool
My 4 Worst-Performing Stocks and What I Think Now
These stocks are all down 70% or more from what I paid. 
Via The Motley Fool
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
25 Meme Stocks to Sell Before They Die
Wondering what the best meme stocks to sell for 2023 are? Here are the top picks that investors should offload and avoid. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
The Worst Investment Decision I Made in 2022
The stock market has had a terrible year, and here are some moves we wish we could do over. 
Via The Motley Fool
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share. 
Via Benzinga
23andMe Survey Shows Majority of People Less Stressed About Their Health During This Holiday Season
From 23andMe Holding Co.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
 
Via Benzinga
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes. 
Via TheNewswire.com
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
BioRestorative Therapies Inc. (NASDAQ: BRTX) is working on products that may be solutions to conditions that affect millions of Americans with lower back pain and diabetes.  
Via Benzinga
23andMe Reports FY2023 Second Quarter Financial Results
From 23andMe Holding Co.
Via Globe NewsWire
23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
The presentation outlines plans for the expansion phase of the study (part B), including the specific tumor indications where 23ME-00610 will be tested for anticancer activity 
From 23andMe Holding Co.
Via Globe NewsWire
A Preview Of 23andMe Holding's Earnings
23andMe Holding (NASDAQ:ME) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that 23andMe Holding... 
Via Benzinga
I Bought 2 SPACs That Haven't Lived Up to Expectations -- Here's Why I'm Still Holding Them
These companies haven't performed as well as I thought they would, but I don't plan to sell. 
Via The Motley Fool
23andMe Granted New FDA Clearance to Provide Interpretive Drug Information for a Commonly Prescribed Cholesterol Medication
FDA 510(k) clearance allows 23andMe to report genetics associated with processing of certain statins, provides interpretive drug information for simvastatin, and removes the requirement for... 
From 23andMe Holding Co.
Via Globe NewsWire
23andMe to Report FY2023 Second Quarter Financial Results
From 23andMe Holding Co.
Via Globe NewsWire
Bill Gates, Warren Buffett's Initiative For Billionaires To Donate Most Of Their Wealth Sees Sharp Drop In Pledgers In 2022
“Giving Pledge” foundation — started by billionaires Bill Gates and Warren Buffett — has seen pledging commitments drop steeply this year, which has been marred by g 
Via Benzinga
2 Budding Growth Stocks That Could Turn $1,000 Into $10,000 in 8 Years
They're both using unique and highly efficient approaches to developing and deploying their medicines. 
Via The Motley Fool
23andMe to Present at Upcoming Investor Conferences
From 23andMe Holding Co.
Via Globe NewsWire
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2022 Annual Meeting
Poster to provide details on study design and expansion phase for ongoing Phase 1 study in patients with advanced solid malignancies 
From 23andMe Holding Co.
Via Globe NewsWire
7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On
Reddit stocks had a bad name once, but over time, Reddit has become a more reliable bellwether for stocks to buy in the short term. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday. 
Via Benzinga
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday. 
Via Benzinga
What Is Going on With Madison Square Garden (MSGE) Stock Today?
Madison Square Garden (MSGE) stock is getting a boost on Friday following approval from its Board to explore a potential spin-off. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.